WARSAW,
Ind., Feb. 27, 2025 /PRNewswire/ -- Zimmer
Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical
technology leader, today announced that Jehanzeb Noor is joining the Company as Senior
Vice President, Chief Strategy, Innovation and Business Development
Officer. He will report to Ivan Tornos, President and CEO of Zimmer
Biomet.
In his new role, Mr. Noor will be responsible for leading
strategy development and execution and all facets of M&A,
including the integration for our pending acquisition of Paragon
28. In addition, he will have oversight of the research and product
development organizations, inclusive of new product and service
development, partnership and ecosystem development, and platform
technologies. He will also serve as the Chief of Staff to the
CEO.
"I'm thrilled to welcome Jehanzeb to Zimmer Biomet," said Mr.
Tornos. "Over the course of his career, Jehanzeb has consistently
demonstrated an impressive track record of significantly improving
execution, culture and results. As we continue to boldly execute
against our strategy and pursue innovation, I am confident Jehanzeb
will be instrumental to our long-term success and deliver value for
patients, surgeons, health systems and shareholders."
Prior to Zimmer Biomet, Mr. Noor served as President and
Managing Director for Europe,
Africa, and Asia at Trivium, where he led Trivium's top
& bottom-line transformation to drive operational excellence
for margin and cash expansion. Prior to Trivium, Mr. Noor was CEO
of Smiths Medical for three years and also held roles of increasing
responsibility at Amcor, McKinsey, Ford Motor Company, and
Constellation Energy Commodities Group.
Mr. Noor holds a Master of Science with a focus on Product
Development, a Bachelor of Science in Finance and a Bachelor of
Science in Mechanical Engineering, all from the Massachusetts Institute of Technology (MIT).
About Zimmer Biomet
Zimmer Biomet is a global medical
technology leader with a comprehensive portfolio designed to
maximize mobility and improve health. We seamlessly transform the
patient experience through our innovative products and suite of
integrated digital and robotic technologies that leverage data,
data analytics and artificial intelligence.
With 90+ years of trusted leadership and proven expertise,
Zimmer Biomet is positioned to deliver the highest quality
solutions to patients and providers. Our legacy continues to come
to life today through our progressive culture of evolution and
innovation.
For more information about our product portfolio, our operations
in 25+ countries and sales in 100+ countries or about joining our
team, visit www.zimmerbiomet.com or follow on LinkedIn at
www.linkedin.com/company/zimmerbiomet or X / Twitter at
www.twitter.com/zimmerbiomet.
Media
|
Investors
|
Heather
Zoumas-Lubeski
|
David
DeMartino
|
445-248-0577
|
646-531-6115
|
heather.zoumaslubeski@zimmerbiomet.com
|
david.demartino@zimmerbiomet.com
|
|
|
|
Zach Weiner
|
|
908-591-6955
|
|
zach.weiner@zimmerbiomet.com
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/zimmer-biomet-appoints-jehanzeb-noor-as-senior-vice-president-chief-strategy-innovation-and-business-development-officer-302386664.html
SOURCE Zimmer Biomet Holdings, Inc.